Management of bile acid diarrhea in Italy: a survey
Internal and Emergency Medicine · 2025
DOI: 10.1007/s11739-025-04060-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal and Emergency Medicine, 2025. Verfasst von Giovanni Marasco und 10 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero Universitaria Di Bologna, Bologna, Italy. giovanni.marasco4@unibo.it. Hauptthemen laut MEDLINE: Diarrhea, Bile Acids and Salts. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Messaggi International Publisher & Events srl, Milan Italy, Alma Mater Studiorum - Università di Bologna.
Abstract (Originalsprache)
Bile acid diarrhea (BAD) is a common, under-investigated cause of chronic diarrhea. We aimed to assess the current management of BAD among a group of Italian physicians. A survey was developed by a task force of experts and distributed via the Internet to Italian physicians members of the main Italian gastroenterological associations. Ninety-four physicians accepted to participate, of whom 44% were females. The majority of participants were gastroenterologists (63%) and the mean age was 50.5 years. No differences in the rate of BAD diagnosis among patients with chronic diarrhea were found according to medical specialization. Gastroenterologists reported a higher prevalence of BAD compared with other physicians/general practitioners (1% vs 0.3%). BAD suspicion is mostly raised in the presence of watery stools and > 3 bowel movements/day and the exclusion of organic/drug-related diseases. BAD diagnosis was assessed with 75SeHCAT (67.8% of gastroenterologists and 51.4% of other physicians), followed by a trial of cholestyramine (30.5% of gastroenterologists and 31.4% of other physicians). Therapies most prescribed for BAD were cholestyramine, a low-fat diet, and stool thickeners. BAD is a common condition generally suspected in the presence of chronic watery diarrhea. 75SeHCAT availability influences the awareness of this disease. Therapies currently are often not able to guarantee adequate symptom relief.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero Universitaria Di Bologna, Bologna, Italy. giovanni.marasco4@unibo.it.
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. giovanni.marasco4@unibo.it.
- IRCCS Azienda Ospedaliero Universitaria Di Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Clinica Medica "A. Murri", Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Bari, Italy.
ORCID-Profile: Giovanni Marasco
Förderung
- Messaggi International Publisher & Events srl, Milan Italy
- Alma Mater Studiorum - Università di Bologna
Zitieren
APA
Marasco, G., Barbara, G., Bellini, M., Portincasa, P., Stanghellini, V., Annibale, B., Benedetti, A., Cammarota, G., Fries, W., Usai Satta, P., & Corazziari, E. S. (2025). Management of bile acid diarrhea in Italy: a survey. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-025-04060-9
Vancouver
Marasco G, Barbara G, Bellini M, Portincasa P, Stanghellini V, Annibale B, et al. Management of bile acid diarrhea in Italy: a survey. Internal and Emergency Medicine. 2025. doi:10.1007/s11739-025-04060-9
BibTeX
@article{Marasco2025,
author = {Marasco, Giovanni and Barbara, Giovanni and Bellini, Massimo and Portincasa, Piero and Stanghellini, Vincenzo and Annibale, Bruno and Benedetti, Antonio and Cammarota, Giovanni and Fries, Walter and Usai Satta, Paolo and Corazziari, Enrico Stefano},
title = {Management of bile acid diarrhea in Italy: a survey},
journal = {Internal and Emergency Medicine},
year = {2025},
doi = {10.1007/s11739-025-04060-9}
}
EUVIMED